Pharmacogenetics of CYP450A, ABCB1, ABCC2, SLCO1B3 gene polymorphisms and plasma alpha-1-acid glycoprotein level on nonhaematological adverse events of docetaxel in Malaysian breast cancer patients

Docetaxel is an antitubulin chemotherapeutic agent approved for the treatment of breast, lung, ovarian and non-hormonal dependent prostate cancers. However, the success of this drug is limited by adverse events (AEs), the severity of which ranges from tolerable to life threatening. Tapering the dose...

Full description

Saved in:
Bibliographic Details
Main Author: Jabir, Rafid Salim
Format: Thesis
Language:English
Published: 2015
Subjects:
Online Access:http://psasir.upm.edu.my/id/eprint/70717/1/FPSK%28P%29%202017%2034%20IR.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!